PulseSight Therapeutics

Test for AMD
#Dry AMD #Geographic atrophy #Ophthalmology #PulseSight Therapeutics

Data support transferrin vectorised therapy for geographic atrophy

New data have revealed the potential of a DNA plasmid expressing human transferrin for the treatment of dry age-related macular degeneration (AMD) and geographic atrophy (GA). PulseSight Therapeutics shared the data on its lead programme PST-611 at the European Association for Vision and Eye Research (EVER)… Read More

#News